Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3154)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 15, 2025 (publication date) through Oct 30, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Qian W, Xu CY, Hong W, Li ZM, Xu DG. Transmembrane protein 176B promotes epithelial-mesenchymal transition in colorectal cancer through inflammasome inhibition. World J Gastrointest Oncol 2025; 17(3): 97673 [PMID: 40092936 DOI: 10.4251/wjgo.v17.i3.97673] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Qian W, Xu CY, Hong W, Li ZM, Xu DG. Transmembrane protein 176B promotes epithelial-mesenchymal transition in colorectal cancer through inflammasome inhibition. World J Gastrointest Oncol 2025; 17(3): 97673 [PMID: 40092936 DOI: 10.4251/wjgo.v17.i3.97673] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v17/i3/97673.htm |
| Number | Citing Articles |
| 1 |
Ji Shi, Duo Zheng, Bing Yao, Qiang Liu, Huizhe Xu, Haozhe Piao. Research progress on TMEM proteins in cancer progression and chemoresistance (Review). International Journal of Molecular Medicine 2025; 56(6): 1 doi: 10.3892/ijmm.2025.5660
|
| 2 |
Abdul L. Shakerdi, Emma Finnegan, Yin-Yin Sheng, Karlo Vidovic, Jessica M. Logan, Mark P. Ward, Sharon A. O’Toole, Cara Martin, Stavros Selemidis, Doug Brooks, John J. O’Leary, Prerna Tewari. Crosstalk Between Inflammasome Signalling and Epithelial-Mesenchymal Transition in Cancer and Benign Disease: Mechanistic Insights, Context-Dependence, and Therapeutic Opportunities. Cells 2025; 14(20): 1594 doi: 10.3390/cells14201594
|